Cornal
transplantion is also known as penetrating keratoplasty, corneal graft, PKP, and
PK. It is a surgical
procedure to remove the diseased part of the cornea and replace it with a
similarly sized and shaped part of a healthy donor cornea.
back to top
Corneal transplantations are performed for
several reasons, including the following:
-
Optical: To improve the
optical qualities of the cornea and thus improve vision
-
Reconstructive: To
reconstruct the anatomic cornea to preserve the eye
-
Therapeutic: To treat a
disease unresponsive to medical management to preserve the eye
The most common indications, in descending
order, are:
-
bullous keratopathy (pseudophakic, Fuchs' endothelial dystrophy,
aphakic);
-
keratoconus;
-
repeat graft;
-
keratitis/postkeratitis (viral, bacterial,
fungal, Acanthamoeba, perforation) and;
-
corneal stromal dystrophies.
The Eye Bank Foundation of the Philippines
operates the Sta. Lucia Eye Bank at the Sentro Oftalmologico Jose Rizal at the
Philippine General Hospital. All donor corneal tissues are processed here.
Tissue matching is not routinely performed or
necessary for the majority of corneal transplants. Corneal tissue from donors
with the following conditions is not used for transplantation: death from
unknown causes, Creutzfeldt-Jakob disease, subacute sclerosing panencephalitis,
progressive multifocal leukoencephalitis, congenital rubella, active
encephalitis, active septicemia, active endocarditis, active syphilis, viral
hepatitis or seropositivity, rabies, HIV seropositivity or high risk for HIV
infection, leukemias, active disseminated lymphomas, prior anterior segment
surgery or disease, and most intraocular malignancies. The donor's blood is
tested for HIV-1, HIV-2, hepatitis B, and hepatitis C. Tissue from donors with
positive serology is not used.
Corneal transplants can be performed using
general or local anesthetic plus IV sedation. To prepare the tissue for
transplantation from the donor cornea, the surgeon punches out a corneal button
from the central part of the donor cornea using a trephine. To create the
recipient bed to receive the donor corneal button, the surgeon removes the
central 60 to 80% of the host cornea using a trephine and scissors. The donor
corneal button, which is trephined slightly larger than the recipient bed, is
then sutured in place.
Postoperative topical antibiotics are used
for several weeks and topical corticosteroids for several months. In some
patients, the corneal astigmatism can be reduced in the early postoperative
period by suture adjustment or selective suture removal. Achievement of full
visual potential may take up to 1 yr because of changing refraction, slow wound
healing, and/or corneal astigmatism. In many patients, earlier and better vision
is attained with a rigid contact lens over the corneal transplant. To protect
the eye from inadvertent trauma after transplantation, the patient wears
shields, glasses, or sunglasses. In addition, patients are advised to avoid
bending over completely, lifting heavy objects, straining, or the Valsalva
maneuver.
Complications include infection (intraocular
and corneal), intraocular bleeding, wound leak, glaucoma, graft rejection, graft
failure, high refractive error (especially astigmatism and/or myopia), and
recurrence of disease, ie, corneal stromal dystrophy.
Graft rejection is not uncommon. Patients
complain of decreased vision, photosensitivity, ocular ache, and ocular redness.
Graft rejection is treated with corticosteroids, which are administered
topically (eg, prednisolone acetate 1% hourly), often with a supplemental
periocular injection (eg, methylprednisolone 40 mg). If the graft rejection is
severe or if the graft function is marginal, additional corticosteroids are
given orally (eg, prednisone 1 mg/kg/day) and occasionally IV (eg,
methylprednisolone sodium succinate 3 to 5 mg/kg once). In most non-high-risk
grafts, the graft rejection episode is easily reversed, and graft function
returns fully. The graft may fail if the graft rejection was unusually severe or
long-standing or after multiple episodes of graft rejection. Regraft is
possible, but the long-term prognosis for a clear regraft is lower than it was
for the original graft.
The prognosis for a clear, functioning
corneal transplant varies by diagnosis. The chance of long-term transplant
success is > 90% for keratoconus, corneal scars, early bullous keratopathy, or
corneal stromal dystrophies; 80 to 90% for bullous keratopathy or inactive viral
keratitis, 50% for active corneal infection, and 0 to 50% for chemical or
radiation injury.
The generally high rate of success of corneal
transplantation is attributable to many factors, including the avascularity of
the cornea and the fact that the anterior chamber has venous drainage but no
lymphatic drainage. These conditions promote low-zone tolerance and an active
process termed anterior chamber-associated immune deviation, in which there is
suppression of intraocular lymphocytes and delayed-type hypersensitivity to
transplanted intraocular antigens. Another important factor is the effectiveness
of the immunosuppressive drugs used to treat graft rejection.
back to
top
There are several ways of reaching the ophthalmologists of EYE REPUBLIC Ophthalmology Clinic:
Hover note: Please place your mouse cursor over the red box
to click on the web and email links. For websites, a new browser
window will open. For emails, your default email program will
open. You may cut and paste the URLs or email addresses if you
prefer not to open new windows.
ONLINE ACCESS
WEBSITES.
http://www.EyeRepublic.com.ph - EYE REPUBLIC
Ophthalmology Clinic
http://www.OCP.com.ph - Ophthalmic
Consultants Philippines Co. -
http://www.LASIK.com.ph - Refractive
Surgery Resource
http://www.Cataract.com.ph - Cataract Surgery Resource
http://www.Eye.com.ph - Eye
Information Online
http://www.EyeDoc4Kids.com.ph - Eye Information for Kids
http://www.Retina.com.ph - Retina
Surgery Resource
http://www.Glaucoma.com.ph - Glaucoma
Online
http://www.Uveitis.com.ph - Uveitis Online
EMAIL. After writing down your comments,
suggestions, problems and/or questions, kindly tell us how
to get in touch with you by providing your name, email,
home/office numbers, and mobile phone.
General inquiries - help@EyeRepublic.com.ph
Refractive Surgery Service - refractive.surgery@EyeRepublic.com.ph
Glaucoma Service - glaucoma@EyeRepublic.com.ph
Cataract Service - cataract@EyeRepublic.com.ph
Doctors - eyemd@EyeRepublic.com.ph
Administrative - president@EyeRepublic.com.ph
Website - webmaster@EyeRepublic.com.ph
Newsletter -
newsletter@EyeRepublic.com.ph (receive
news and updates, discounts and promotions)
BLOG. Send us your comments.
EYE REPUBLIC
Ophthalmology Atlas
CLINIC INFORMATION
Mobile E-Yellow Pages. Via
SMS, text LUK4 EYEREPUBLIC
(send to 2851 for Globe and Sun Cellular, and 2951 for Smart). |
EYE REPUBLIC Ophthalmology Clinic
Manila
3/F Don Santiago Building Units 309-310
1344 Taft Avenue, Ermita
Manila, 1000 Philippines
Direct and Fax: (632) 536-2398
Trunk Line: (632) 523-8271 to 79 local 30
Mobile: (63917) 899-2020
Map and directions
|
EYE REPUBLIC
Ophthalmology Clinic
Asian Hospital
and Medical Center
5/F Medical Office
Building (MOB) Suite 509
2205 Civic Drive,
Filinvest, Alabang
Muntinlupa City,
1781 Philippines
Direct:
(632) 771-9253
Direct and Fax:
(632) 771-9254
Mobile: (63917) 795-2020
Map and Directions
|
EYE REPUBLIC Ophthalmology Clinic
Medical City
6/F Medical Arts Tower Inc (MATI) Suite 602
MERALCO Compound, Ortigas Avenue
Pasig City, 1604, Philippines
Direct and Fax: (632) 632-7846
Mobile: (63917) 537-2020
Map and directions
|
EYE REPUBLIC
Ophthalmology Clinic
St. Luke's
Medical Center
6/F
Cathedral Heights Building Complex (CHBC)
North Tower Suite 614
279 E. Rodriguez
Sr. Boulevard
Quezon City, 1102
Philippines
Direct and Fax:
(632) 407-3883
Mobile: (63917) 855-2020
Map and directions
|
CLINIC HOURS
First-Come, First-Served
Monday to Saturday 9:00 AM to 6:00 PM
All clinics are closed on Sundays and Holidays
|
|
back to top
CORNEAL TRANSPLANTATION information compiled by
Dr. Manolette R.
Roque and initially uploaded on February 23, 2006.
Last updated on
September 13, 2007.
|